These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 8882383)
1. Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections. Dunn CJ; Barradell LB Drugs; 1996 Mar; 51(3):483-505. PubMed ID: 8882383 [TBL] [Abstract][Full Text] [Related]
2. Azithromycin. A review of its use in paediatric infectious diseases. Langtry HD; Balfour JA Drugs; 1998 Aug; 56(2):273-97. PubMed ID: 9711451 [TBL] [Abstract][Full Text] [Related]
3. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Peters DH; Friedel HA; McTavish D Drugs; 1992 Nov; 44(5):750-99. PubMed ID: 1280567 [TBL] [Abstract][Full Text] [Related]
4. Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients. Langtry HD; Brogden RN Drugs; 1997 Jun; 53(6):973-1004. PubMed ID: 9179528 [TBL] [Abstract][Full Text] [Related]
6. Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae. Berry V; Thorburn CE; Knott SJ; Woodnutt G Antimicrob Agents Chemother; 1998 Dec; 42(12):3193-9. PubMed ID: 9835514 [TBL] [Abstract][Full Text] [Related]
7. History of macrolide use in pediatrics. Klein JO Pediatr Infect Dis J; 1997 Apr; 16(4):427-31. PubMed ID: 9109154 [TBL] [Abstract][Full Text] [Related]
8. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections. Perry CM; Scott LJ Drugs; 2004; 64(13):1433-64. PubMed ID: 15212560 [TBL] [Abstract][Full Text] [Related]
10. Azithromycin in lower respiratory tract infections. Lode H; Schaberg T Scand J Infect Dis Suppl; 1992; 83():26-33. PubMed ID: 1336893 [TBL] [Abstract][Full Text] [Related]
11. The macrolides: erythromycin, clarithromycin, and azithromycin. Alvarez-Elcoro S; Enzler MJ Mayo Clin Proc; 1999 Jun; 74(6):613-34. PubMed ID: 10377939 [TBL] [Abstract][Full Text] [Related]
12. Properties of azithromycin that enhance the potential for compliance in children with upper respiratory tract infections. Powers JL Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S30-7. PubMed ID: 8878244 [TBL] [Abstract][Full Text] [Related]
13. Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections. Yassin HM; Dever LL Expert Opin Investig Drugs; 2001 Feb; 10(2):353-67. PubMed ID: 11178347 [TBL] [Abstract][Full Text] [Related]
14. The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections. Soepandi P; Mangunnegoro H; Yunus F; Gunawan J Respirology; 1998 Jun; 3(2):113-7. PubMed ID: 9692520 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetic and clinical evaluation of azithromycin using fine granules or capsules in the pediatric patients]. Toyonaga Y; Ishihara T; Nakamura H Jpn J Antibiot; 1996 Nov; 49(11):981-93. PubMed ID: 8988410 [TBL] [Abstract][Full Text] [Related]
17. Review of macrolides and ketolides: focus on respiratory tract infections. Zhanel GG; Dueck M; Hoban DJ; Vercaigne LM; Embil JM; Gin AS; Karlowsky JA Drugs; 2001; 61(4):443-98. PubMed ID: 11324679 [TBL] [Abstract][Full Text] [Related]
18. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States. Croom KF; Goa KL Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657 [TBL] [Abstract][Full Text] [Related]